- Software-as-a-services (SAAS) and cloud intelligent systems provider WeTrade Group Inc WETG is in an advanced discussion with Zhixun Biotechnology Limited to launch an in-depth cooperative sales promotion of Zhixun's disinfectant - Zhuchang, in China and international markets.
- The financial terms of the transaction remain undisclosed.
- Zhixun specializes in the production of medical sterilization products.
- Also Read: WeTrade's Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits?
- Zhuchang disinfectant is a portable spray, officially registered with the PRC government, being the only and one-of-a-kind product in the market that can eliminate the COVID-19 Omicron variant.
- CEO Pijun Liu commented, "The potential partnership between Wetrade and Zhixun will not only enhance the sales of Zhixun's one-of-a-kind disinfectant to the next level but also expand WeTrade's space in the medical area, which will become a strong and new growth driver for the Group."
- Price Action: WETG shares traded higher by 19.10% at $8.53 on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in